Literature DB >> 11151754

A new look at the heart in diabetes mellitus: from ailing to failing.

E Standl1, O Schnell.   

Abstract

UNLABELLED: This review discusses some of the mechanisms inherent in diabetes that predispose patients to increased cardiac morbidity and mortality. Single photon emission computerized tomography or photon emission tomography with radioactive labeled analogues of norepinephrine have shown that cardiac sympathetic dysfunction and incompetence are early and also late abnormalities in patients with Type I (insulin-dependent) and Type II (non-insulin-dependent) diabetes mellitus. Furthermore, myocardial blood flow assessment with photon emission tomography has shown that in patients without myocardial perfusion deficits, endothelial-dependent vasodilatation is severely reduced in relation to cardiac sympathetic dysfunction. In addition, signs of endothelial activation have also been found early in patients with Type I and Type II diabetes in whom vascular disease has not been clinically detected. This activation in conjunction with glycaemic control is important in determining macrovascular mortality. Cardiac sympathetic dysfunction is partially restored to normal with near normalisation of glycaemia. INTERPRETATIONS: Recently unrecognized "subtle" changes predispose the heart to failure, after ischaemia-induced remodelling, and arteriosclerotic plaques to instability and rupture. These changes act in conjunction with effects, driven by hyperglycaemia and diabetes, on the endothelium of large blood vessels, e.g. on nitric oxide release or on protein kinase-C beta activation. Meticulous glucose control early on and rapid recompensation of hyperglycaemia in patients with acute coronary syndrome are part of a successful intensive multifactorial approach to prevent the heart in diabetes converting from ailing to failing.

Entities:  

Mesh:

Year:  2000        PMID: 11151754     DOI: 10.1007/s001250051556

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  15 in total

Review 1.  The role of PCI and CABG in the management of coronary artery disease in patients with diabetes.

Authors:  Robert L Frye; Malcolm R Bell; Hartzell V Schaff; Richard Holubkov; Katherine M Detre
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

2.  Albumin excretion in diabetic patients in the setting of acute myocardial infarction: association with 3-year mortality.

Authors:  G Berton; R Cordiano; R Palmieri; R De Toni; G L Guarnieri; P Palatini
Journal:  Diabetologia       Date:  2004-08-18       Impact factor: 10.122

3.  Effects of telmisartan or amlodipine monotherapy versus telmisartan/amlodipine combination therapy on vascular dysfunction and oxidative stress in diabetic rats.

Authors:  Hanke Mollnau; Matthias Oelze; Elena Zinßius; Michael Hausding; Zhixiong Wu; Maike Knorr; Jasmin Ghaemi Kerahrodi; Swenja Kröller-Schön; Thomas Jansen; Christine Teutsch; Carolyn Foster; Huige Li; Philip Wenzel; Eberhard Schulz; Thomas Münzel; Andreas Daiber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-02-27       Impact factor: 3.000

Review 4.  Metabolic and additional vascular effects of thiazolidinediones.

Authors:  Fabrice M A C Martens; Frank L J Visseren; Jacinthe Lemay; Eelco J P de Koning; Ton J Rabelink
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 5.  Heart disease in diabetic patients.

Authors:  Mihaela C Blendea; Samy I McFarlane; Esma R Isenovic; Gregory Gick; James R Sowers
Journal:  Curr Diab Rep       Date:  2003-06       Impact factor: 4.810

6.  A mathematical model of the electrophysiological alterations in rat ventricular myocytes in type-I diabetes.

Authors:  Sandeep V Pandit; Wayne R Giles; Semahat S Demir
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

7.  Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus.

Authors:  Shigeki Nagamachi; Seigo Fujita; Ryuichi Nishii; Shigemi Futami; Shozo Tamura; Masanari Mizuta; Masamitsu Nakazato; Takeshi Kurose; Hideyuki Wakamatsu
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

8.  Voltage-dependence of contraction in streptozotocin-induced diabetic myocytes.

Authors:  N K Bracken; A J Woodall; F C Howarth; J Singh
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

9.  Dipeptidyl-peptidase-4 Inhibitors and Heart Failure: Class Effect, Substance-Specific Effect, or Chance Effect?

Authors:  Eberhard Standl; Michael Erbach; Oliver Schnell
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-12

Review 10.  The Munich Myocardial Infarction Registry: translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice.

Authors:  Oliver Schnell; Wolfgang Otter; Eberhard Standl
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.